Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	181.7	82.55	48.34	25.71
Cash & Short-Term Investments	181.7	82.55	48.34	25.71
Cash Growth	254.28%	70.75%	88.07%	-
Accounts Receivable	-	-	-	1.5
Other Receivables	-	0.01	0.33	0.25
Receivables	-	0.01	0.33	1.74
Prepaid Expenses	1.55	0.52	0.33	0.24
Other Current Assets	0.28	2.31	0.21	-
Total Current Assets	183.53	85.39	49.22	27.68
Property, Plant & Equipment	7.58	1.23	1.58	1.06
Other Long-Term Assets	0.5	0.01	0.06	0.05
Total Assets	191.61	86.63	50.85	28.79
Accounts Payable	2.25	1.07	1.61	0.6
Accrued Expenses	7.52	3.5	3.67	0.93
Current Portion of Leases	0.72	0.13	0.28	-
Other Current Liabilities	-	0.92	-	0.28
Total Current Liabilities	14.02	5.61	5.56	1.81
Long-Term Debt	6.63	9.86	9.47	-
Long-Term Leases	4.62	-	0.12	-
Total Liabilities	26.56	15.47	15.15	1.81
Common Stock	0	-	-	0
Additional Paid-In Capital	288.34	5.37	2.3	0.49
Retained Earnings	-123.2	-76.97	-40.66	-12.95
Comprehensive Income & Other	-0.1	-0.08	-0.05	-0.02
Total Common Equity	165.05	-71.67	-38.41	-12.48
Shareholders' Equity	165.05	71.16	35.71	26.98
Total Liabilities & Equity	191.61	86.63	50.85	28.79
Total Debt	15.49	9.99	9.87	-
Net Cash (Debt)	166.21	72.56	38.47	25.71
Net Cash Growth	302.11%	88.60%	49.67%	-
Net Cash Per Share	8.82	19.45	11.16	10.65
Filing Date Shares Outstanding	26.97	26.86	3.69	2.41
Total Common Shares Outstanding	26.97	3.81	3.69	2.41
Working Capital	169.51	79.78	43.66	25.87
Book Value Per Share	6.12	-18.81	-10.40	-5.17
Tangible Book Value	165.05	-71.67	-38.41	-12.48
Tangible Book Value Per Share	6.12	-18.81	-10.40	-5.17
Machinery	2.59	1.27	1.2	0.88

Source: S&P Capital IQ. Standard template. Financial Sources.